SZOSTAK M ANNE 4

4 · IDEXX LABORATORIES INC /DE · Filed May 8, 2025

Form 4

Period: 2025-05-06

Director

Transactions

Award
Non-Qualified Stock Option (right-to-buy)
2025-05-07+600→ 600 total
Exercise: $486.61Exp: 2035-05-06→ Common Stock (600 underlying)
Award
Restricted Stock Unit
2025-05-07+257→ 257 total
→ Common Stock (257 underlying)
Exercise/Conversion
Common Stock
2025-05-06+262→ 262 total
Exercise/Conversion
Restricted Stock Unit
2025-05-06−262→ 0 total
→ Common Stock (262 underlying)

Holdings

Footnotes (4)

[F1]The reporting person is the settlor of the Trust of M. Anne Szostak ("Trust") and the trustee of the Trust, has power to direct the distribution of Trust assets, and has the power to revoke or amend the Trust. The reporting person has a pecuniary interest in the shares held by the Trust.
[F2]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event was earlier.
[F3]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event is earlier.
[F4]Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event earlier.

Documents

1 file